IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
IpiNovyx Bio has raised $10.0M in total funding. The most recent round was Seed. The last funding was announced in October 2021.
IpiNovyx Bio's investors include Alexandria Venture Investments, Orange Grove Bio, Pathway Bioventures, Generation Ventures, Patrick Spaulding Ryan.
IpiNovyx Bio is headquartered in West Nyack, United States.
IpiNovyx Bio is a biopharmaceutical company developing immunoproteasome-modulating therapeutics to treat autoimmune diseases.
IpiNovyx Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"IpiNovyx Bio — Funding & Investors." VCBacked, October 5, 2021, https://www.vcbacked.co/company/ipinovyx-bio. Accessed August 14, 2026.
VCBacked. (2021). IpiNovyx Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/ipinovyx-bio
{{cite web |title=IpiNovyx Bio — Funding & Investors |url=https://www.vcbacked.co/company/ipinovyx-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated